Stay updated with breaking news from Josephf mcguire. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
-Expanded clinical development presence is expected to accelerate activities for THIO-101 Phase 2 Trial for NSCLC- MAIA Biotechnology, Inc., a targeted therapy, immuno-oncology company focused on ....